DODGX | SJVAX | DODGX / SJVAX | |
Total Expense Ratio | 0.51 | 1.00 | 51% |
Annual Report Gross Expense Ratio | 0.51 | 1.26 | 40% |
Fund Existence | 61 years | 4 years | - |
Gain YTD | 7.647 | 6.405 | 119% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 93.3M | 122,186% |
Annual Yield % from dividends | 1.38 | 1.20 | 115% |
Returns for 1 year | 8.33 | 10.32 | 81% |
Returns for 3 years | 31.93 | 46.70 | 68% |
Returns for 5 years | 79.15 | N/A | - |
Returns for 10 years | 63.83 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSGZX | 16.30 | 0.18 | +1.12% |
MassMutual Small Cap Gr Eq I | |||
TLASX | 11.85 | 0.09 | +0.77% |
Transamerica Large Core ESG R6 | |||
IFPUX | 21.80 | 0.13 | +0.60% |
Independent Franchise Partners US Equity | |||
SHPCX | 12.93 | 0.07 | +0.54% |
Saratoga Health & Biotechnology C | |||
HFQIX | 6.90 | 0.01 | +0.15% |
Janus Henderson Global Equity Income I |